drugset / Trial / NCT00224419

Testing Pharmacological Therapies for Pregnant Smokers

NCT00224419 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Nicotine dependence has not been sufficiently addressed in current state-of-the-science cessation interventions for pregnant smokers. The weight of the evidence from the general population of smokers suggests that nicotine replacement therapies may be beneficial cessation aids for pregnant smokers who are unable to stop smoking. The tremendous potential of these therapies for promoting smoking cessation among pregnant women creates a pressing need for decision tools and protocols to encourage treatment adherence that is essential for rigorous evaluation of the effectiveness of OTC NRT when provided as part of prenatal care. The results of this research could be directly translated to the improvement of obstetrical care providers' clinical practices. Medically supervised use of OTC NRT by pregnant smokers is an alternative to continued smoking that has the potential to substantially increase rates of smoking cessation during pregnancy.

Timeline

Start
2003-06
Primary completion
2006-08
Completion
—

Outcome

Outcome not reported

Stopped: “was terminated due to meeting a priori stopping rule set by DSMB”

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg —
Subject Nicotine Unknown 14 mg —
Subject Nicotine Unknown 21 mg —

Indications